Detalles de la búsqueda
1.
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Cancer
; 127(6): 865-874, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33231873
2.
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Ann Intern Med
; 165(9): 625-634, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27537841
3.
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
Lipids Health Dis
; 15(1): 116, 2016 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27405296
4.
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
Liver Cancer
; 10(3): 275-284, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34239813
5.
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
JAMA Oncol
; 7(6): 895-902, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33792646
6.
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.
J Clin Oncol
; 38(3): 193-202, 2020 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31790344
7.
Flushing profile of extended-release niacin/laropiprant at initiation of therapy in Asian lipid clinic patients.
Cardiology
; 114(3): 192-8, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19602880
8.
A cross-sectional study of bone turnover markers in healthy premenopausal women.
Bone
; 40(5): 1222-30, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17331821
9.
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.
J Clin Endocrinol Metab
; 91(7): 2631-7, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16636120
10.
Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.
J Bone Miner Res
; 20(1): 141-51, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15619680
11.
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.
J Clin Endocrinol Metab
; 90(6): 3215-24, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15797954
12.
A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.
Am J Geriatr Pharmacother
; 3(3): 127-36, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16257815
13.
Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model.
Fundam Clin Pharmacol
; 29(2): 209-18, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25431239
14.
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
Vasc Health Risk Manag
; 11: 165-72, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25750540
15.
Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis.
Menopause
; 11(4): 405-15, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15243278
16.
Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial.
Clin Ther
; 24(4): 490-503, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12017395
17.
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.
Curr Med Res Opin
; 20(12): 2031-41, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15706659
18.
Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial.
Curr Med Res Opin
; 20(6): 939-49, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15200753
19.
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.
Vasc Health Risk Manag
; 10: 279-90, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24855368
20.
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
Int J Cardiol
; 167(1): 225-31, 2013 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22305632